AM-109

N/A

Report date: 2024/01/09 17:52:11

Base Information

Drug NameAM-109

Drug Alias NameAM-109

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 9Anti-PSMA

TargetsTumor necrosis factor receptor superfamily member 9Prostate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbclon Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbclon Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A